Altitude Crest Partners
Latest statistics and disclosures from Altitude Crest Partners's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001986035
Tip: Access up to 7 years of quarterly data
Positions held by Altitude Crest Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Altitude Crest Partners
Altitude Crest Partners holds 12 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 21.8 | $33M | 542k | 60.17 |
|
|
| Bridgebio Pharma (BBIO) | 20.4 | $31M | 755k | 40.37 |
|
|
| Danaher Corporation (DHR) | 18.8 | $28M | 122k | 231.34 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 7.5 | $11M | 30k | 380.43 |
|
|
| BioMarin Pharmaceutical (BMRN) | 7.4 | $11M | 114k | 96.42 |
|
|
| Apellis Pharmaceuticals (APLS) | 6.1 | $9.1M | 152k | 59.86 |
|
|
| Roivant Sciences SHS (ROIV) | 6.1 | $9.1M | 808k | 11.23 |
|
|
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 5.4 | $8.0M | 456k | 17.54 |
|
|
| EXACT Sciences Corporation (EXAS) | 4.9 | $7.3M | 99k | 73.98 |
|
|
| Aligos Therapeutics (ALGS) | 1.3 | $1.9M | 2.8M | 0.66 |
|
|
| Ambrx Biopharma | 0.4 | $614k | 43k | 14.24 |
|
|
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $7.7k | 385k | 0.02 |
|
Past Filings by Altitude Crest Partners
SEC 13F filings are viewable for Altitude Crest Partners going back to 2023
- Altitude Crest Partners 2023 Q4 filed Feb. 14, 2024